07:30 AM EST, 11/05/2026 (MT Newswires) -- The European Commission cleared the joint acquisition of Swiss pharmaceutical company InfoRLife by British investment company BC Partners and Italian chemical-pharmaceutical company ACS Dobfar. The regulator said Thursday that the deal, which concerns the pharmaceutical sector, would not raise competition concerns due to the joint venture's negligible activities in the European Economic Area.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.